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Abstract The absence of laboratory tests and clear criteria to identify homogeneous (sub)groups in 
patients presenting with unexplained fatigue, and to assess clinical status and disability in these patients, 
calls for further assessment methods. In the present study, a multi-dimensional approach to the assessment 
of  chronic fatigue syndrome (CFS) is evaluated. Two-hundred and ninety-eight patients with CFS 
completed a set of  postal questionnaires that assessed the behavioural, emotional, social, and cognitive 
aspects of  CFS. By means o f  statistical analyses nine relatively independent dimensions of CFS were 
identified along which CFS-assessment and CFS-research can be directed. These dimensions were named: 
psychological well-being, functional impairment in daily life, sleep disturbances, avoidance of  physical 
activity, neuropsychological impairment, causal attributions related to the complaints, social functioning, 
self-efficacy expectations, and subjective experience o f  the personal situation. A description of  the study 
sample on these dimensions is presented.
IN T R O D U C T IO N
T he  chronic fatigue syndrome (CFS) is characterized by severe disabling fatigue of 
unknown origin. Several operational definitions [1,2] have proved to be unsatisfac­
tory in identifying cases of  CFS [3, 4]. A major problem with these criteria is that they 
are mainly symptom-based. Fatigue, the main symptom in CFS, is a nonspecific 
complaint as reported in the general population as such [5] and in a substantial 
number o f  patients seen in primary care settings [6, 7]. Moreover, fatigue is a 
prominent symptom in a variety of  physical and psychiatric illnesses. Fatigue is not 
only nonspecific, but as a phenomenon it is also difficult to understand. Kennedy [8], 
reviewing the literature on fatigue, concluded that ‘the status of  fatigue as a 
physiological response, psychological perception, or symptom o f  physical and 
psychiatric diseases remains unclear'. T o  date, no clear definition o f  fatigue exists, 
resulting in problems in measurement [9].
Not only is fatigue highly nonspecific, but so are other symptoms commonly 
observed in CFS. Patients with CFS show a considerable overlap in symptoms with 
patients with clinical depression and those with chronic neuromuscular diseases [ 10] 
and chronic pain [11]. Thus symptoms alone seem to have little diagnostic value. 
Neither do laboratory tests contribute to the assessment of  CFS [12-15].
The absence o f  laboratory tests and clear criteria for identifying homogeneous
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(sub)groups in patients presenting with unexplained chronic fatigue and assessing 
clinical status and disability in these patients calls for other assessment methods [3]. In 
the present study, a multi-dimensional approach to the assessment of CFS will be 
used. Behavioural, emotional, social, and cognitive aspects of CFS are measured. The 
main aims of this study are to identify dimensions of CFS and to provide a 
description of patients presenting with unexplained chronic fatigue using these 
dimensions.
SUBJECTS A N D  M E T H O D
Subjects
In the present study the following inclusion and exclusion criteria have been applied [4j: patients had to 
experience severe disabling fatigue, of  definite onset, lasting for more than 1 year; other symptoms may be 
present. Patients with established medical conditions known to produce chronic fatigue, and patients with a 
diagnosis of  schizophrenia, bipolar-disorder, psychotic depression, substance use disorder, eating disorder, 
or proven organic brain disease were excluded.
Three-hundred and ninety-five self-referred patients were sent a postal questionnaire. Ninety per cent 
completed and returned the questionnaire ( N =  357). Detailed information on present illness, specialist 
visits, and treatment was obtained. Based on this information, respondents with definite or suspected 
illnesses that could provide an explanation for the complaints were excluded (e.g. patients taking 
medication for heart problems). Patients who had not been examined by at least one specialist for their 
complaints (10 patients) also were excluded from the analyses. These inclusion and exclusion procedures 
resulted in a study sample of 298 subjects.
Instruments
Fatigue questionnaire. We participated in the development of  the Checklist Individual Strength (CIS) by 
the University Hospital of Amsterdam and the University Hospital of  Rotterdam. This 24-item question­
naire was designed to measure several aspects o f  fatigue. Each item is scored on a 7-point Likert scale. 
Principal components analyses yielded a four-factor solution. Four items that had a low loading on their 
primary factor or that loaded substantially on more than one factor were deleted. These factors were easy 
to interpret and were named: ( 1 ) subjective experience of fatigue (8 items); (2) concentration (5 items); (3) 
motivation (4 items); (4) physical activity level (3 items). The final subscales accounted for 67.7% of the 
variance. Psychometric properties were excellent: C ronbach’s alpha reliability coefficient for the entire CIS 
was 0.90. Gutman split-half reliability coefficient was 0.92. Cronbach's alphas for the subscales were 0.88, 
0.92, 0.83 and 0.87 respectively. Data from two comparison groups are available. The first group consists of 
healthy subjects {N = 60: mean age = 32 yr). The second group are patients with functional bowel disorder 
(FBD) (N =  61: mean age =  41 yr).
Self-reported complaints. Symptom assessment was based on spontaneous reports by the patient. 
Patients were asked to write down their complaints. Information concerning the course and duration o f  the 
complaints was also obtained.
Psychological well-being. The Beck Depression Inventory (BDI) [16J is a standardized self-report 
questionnaire used to measure depression. Four diagnostic categories are based on the total score: 0 -  
9 = nondepressed; 10-15 =  mildly depressed; 16 23 = moderately depressed; 24 or more = severely de­
pressed. A score of 16 or more is indicative of a clinical depression. The Symptom Checklist (SCL-90) [ 17] is 
a 90-item indicator of psychopathology and screens for anxiety (SCL-ANX), agoraphobia (SCL-AGO), 
depression (SCL-DEP). somatization (SCL-SOM), cognitive difficulties (SCL-IN), interpersonal sensitivity 
(SCL-SEN), hostility (SCL-HOS). and sleep disturbances (SCL-SLP). A total score called the psychoneur- 
oticism score (SCL-PSN) can be obtained. Comparison data are available for normal subjects (N =  1009; 
mean age = 43 yr). for a mixed psychiatric out-patient group (N  =  2118; mean age = 36 yr) [17], and for a 
group of patients with functional bowel disorder (FBD) {N =  103; mean age =  44 yr).
Daily functioning. The effect of the complaints on daily functioning was assessed by the Sickness Impact 
Profile (SIP) [18, 19], using the following eight subscales: home management (S1P-HM), mobility (SIP-
MOB), alertness behaviour (SIP-AB), sleep/rest (SIP-SR), ambulation (SIP-A), social interactions (SIP- 
SI), work (SIP-W), and recreation and pastimes (SIP-RP). Comparison data are available for two groups 
of  patients registered at five family practices situated in urban, suburban, and rural areas [19], The first 
group (N = 450; mean age =  47 yr) reported physical complaints of minor severity or no physical 
complaints at all. The second group (N =  144; mean age =  49 yr) reported moderate to severe physical
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complaints (gastrointestinal, hack pain, arthralgia, and cardiovascular complaints).
In addition to the SIP, general questions regarding daily functioning were included: these assessed the 
patient's opinion concerning: (a) the extent to which their complaints interfered with daily activities (4- 
point scale); (b) problems in housekeeping activities and work (5-point scale); (c) satisfaction in 
housekeeping activities and work (5-point scale).
Avoidance behaviour. Avoidance of  physical activity is thought to play a role in the perpetuation of the 
complaints in CFS [20. 2IJ. Therefore, four questions were asked with respect to avoidance of physical 
activity as a way of coping with complaints (e.g. ‘avoiding complaints by nonactivity'). The level of 
physical activity is assessed by the CIS-Activity subscale (see the section Fatigue questionnaire).
Cognitions and attributions. Cognitions were assessed by: (a) a specific 3-point scale question concerning 
self-efficacy expectations ( ‘do you think you can influence your complaints?’); (b) causal attributions: 
patients were asked to write down their opinions regarding the causes of the complaints. These responses 
were coded into the dichotomous variables ‘physical causes' and ‘non-physical causes'; (c) the Multi­
dimensional Health Locus of  Control questionnaire (MHLC) [22, 23] which measures control beliefs with 
respect to health in general. The MI ILC contains three subscales: internal attributions (MHLC-I: health is 
determined by own behaviour/capacities); external attributions (MHLC-E: health is determined by fate/ 
chance); and powerful others (MI 1LC-P: health is determined by partners/fricnds/doctors). MHLC-data  of 
a comparison group of patients with FBD are available (N — 103; mean age =  44 yr).
Social interactions. General questions were asked concerning: (a) satisfaction with social life (5-point 
scale); (b) problems in social relations (4-point scale); (c) the SIP contains a subscale assessing the elTect of 
the complaints on social life (SIP-SI: sec section Daily functioning).
Sleep disturbances, (a) A general sleep disturbanccs-question, which is coded ‘yes' or ‘no': (b) a question 
with respect to the type o f  the sleep disturbance (problems falling asleep, restless sleep, and early awakening 
in the morning); (c) duration of sleep at night and during the day; (d) the SCL-90 contains a subscale on 
sleeping problems (SCL-SLP: sec section Psychological well-being).
In addition to the above mentioned instruments information on age, sex, marital status, occupation, and 
education was obtained.
STATISTICAL ANALYSES
Testing differences between groups was performed by analyses of variance 
(ANOVA). When appropriate, covariates were included in the ANOVA. The 
identification of dimensions of the CFS was a four-step procedure: (I) Principal 
components analyses on all subscales and the general questions. Variables that had 
low factor loadings or that loaded substantially on more than one factor were 
excluded; (II) Per factor the included variables were weighted in order to achieve 
approximately equal standard deviations; (III) Per factor reliability procedures were 
performed on the weighted variables (Cronbach's a). Variables that suppressed alpha 
were excluded. For each dimension a score was obtained by summing the scores of the 
variables belonging to the dimension; (IV) Stepwise multiple regression analyses were 
performed on the dimension scores in order to evaluate interrelations.
In analyses in which more than 5% of cases were excluded because of missing 
values, these values were replaced by means of the linear trend at point method, which 
is available in SPSS (release 6.0). For each variable, the existing series was regressed 
on an index variable, scaled 1 to n. Missing values were replaced with their predicted 
value.
RESULTS
Descriptive
Biographical. Mean age was 39 yr (range 18-73). There were 75 males and 223 
females. Fifty-five per cent of patients were married or cohabiting, 34% were single, 
8% were divorced, and 3% were widowed. Only 31 % of patients reported being still at
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work, whereas 58% worked before the onset of the complaints. Of the patients 
presently working, 80% worked part-time because of the complaints. All patients had 
visited at least one specialist for their complaints (internist: 81%; neurologist: 59%; 
psychologist: 35%; psychiatrist: 32%; rheumatologist: 19%).
Spontaneously reported complaints are presented in Table I. Only complaints 
reported by at least 10% of patients are included in the table. The average number of 
complaints reported is 8 (s d  =  3.8). Median duration for the complaints was 5 yr.
Subjective feeling o f  fatigue ( CIS-Subjective Fatigue). Data are presented in Table
II. Overall analyses of variance revealed group differences on CIS-Subjective Fatigue 
(/? < 0.001: age and sex were entered as covariates in the analyses). Patients with CFS 
reported more fatigue than healthy subjects and patients with FBD, FBD-patients 
reported more fatigue than healthy subjects.
T a b l e  I.—S p o n t a n e o u s l y  r e p o r t e d  c o m p l a i n t s  b y
298 CFS-p a t i e n t s
Complaint % (N)
Myalgia 71 (210)
Difficulty concentrating 51 (151)
Gastrointestinal complaints 49 (145)
Headache 46 (136)
Dizziness 43 (127)
Sleep disturbances 43 ( 122)
Memory problems 36 (106)
Muscle weakness 35 (103)
Recurrent infections 26 (77)
Irritability 24 (72)
Depression 12 (66 )
Changes in body temperature 21 (63)
Speech disturbances 20 (59)
Visual disturbances 19 (57)
Arthralgia 17 (52)
Polvuria«r 16 (48)
Excessive transpiration 16 (48)
Coordination disturbances 15 (45)
Emotional lability 15 (44)
Sore throat 13 (39)
Allergies 12 (36)
T a b l e  II.—M e a n  CIS s c o r e s  ( s d )  o f  298 p a t i e n t s  w i t h  c h r o n i c
FATIGUE SYNDROME (CFS), 61 PATIENTS WITH FUNCTIONAL BOWEL 
DISORDER (FBD), AND 60 HEALTHY SUBJECTS. H l G H  SCORES INDICATE A 
HIGH LEVEL OF FATIGUE, A HIGH LEVEL OF CONCENTRATION PROBLEMS, 
LOW MOTIVATION, AND A LOW LEVEL OF PHYSICAL ACTIVITY
Subscales CFS FBD Healthy
Subjective fatigue 6.1 ( 1.0 ) 4.4 (1.8) 2.4 (1.4)
Concentration 4.8 (1.8) 3.6 (1.7) 2.2 ( 1.2 )
Motivation 4.0 (1.7) 3.4 (1.6) 2.0 ( 1.0 )
Activity 5.0 (1.7) 3.3 (1.9) 2.0 (1.3)
On all subscales, CFS-patients scored significantly higher than FBD- 
patients and healthy controls (p <  0.001), and FBD-patients scored 
significantly higher than healthy controls (/; < 0 .001 ).
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Psychological well-being. SCL-90 data of CFS-patients, psychiatric out-patients, 
FBD-patients, and healthy subjects are depicted in Table III. As sex is related to SCL- 
90 scores [17], this variable was entered as a covariate in analyses of variance. Overall 
analyses revealed group differences on all subscales (p < 0.001). Significant dif­
ferences between groups are displayed in Table 3. On the BDI, 32% of patients did 
not have depressed feelings at all. Using a score of 16 or more, 36% of patients could 
be considered as having a clinical depression.
Daily functioning. Ninety-three per cent of patients reported that they experienced 
severe impairment in daily life because of their complaints, 7% reported moderate 
impairment. Sixty-two per cent reported marked problems in activities at home or at 
work, and 70% reported not being satisfied with respect to daily functioning. Data on 
the SIP arc presented in Table IV. Overall analyses of variance showed group 
differences on all subscales (p < 0.001).
Avoidance behaviour. Only 4% of patients did not score on any of the four items 
measuring avoidance of physical activity, 1 1% scored on one item, 17% scored on
T a b l e  III. M e a n  SCL-90 s c o r e s  ( s d )  o f  290 p a t i e n t s  w i t h  c h r o n i c  f a t i g u e  s y n d r o m e  (CFS), 103
PATIENTS WITH FUNCTIONAL BOWEL DISORDER (FBD), 1009 HEALTHY SUBJECTS, AND 21 18 PSYCHIATRIC
OUT-PATIENTS
Healthy FBD CFS Psychiatric
ANX 13.9 (5.2)** 17.0 (7.1) 17.9 (6.9) 26.0 (9.9)**
AGO 8.4 (2.9)** 9.3 (4.3) 9.7 (4.4) 13.9 (7.3)**
DEP 22.5 (7.9)** 26.9 (10.2)** 31.2 (11.3) 42.2 (15.0)**
SOM 17.8 (6 .6 )** 23.7 (9.4)** 30.6 (8.7) 26.6 ( 10.0 )**
IN 13.7 (4.9)** 17.7 (6.5)** 23.0 (7.3) 21.7 (8.2)*
SEN 25.6 (8.0)** 27.2 (9.0) 27.9 (10.2) 39.1 (15.5)**
HOS 7.6 (2.4)** 8.2 (2.4) 8.7 (3.4) 11.6 (5.3)**
SLP 4.9 (2.7)** 6.5 (3.4) 7.5 (6.5) 7.8 (3.7)
PSN 123.9 (33.3)** 147.8 (45.2)** 167.8 (48.7) 206.0 (65.6)**
*Significantly different from CFS: p < 0.05. 
**Significantly different from CFS: p < 0.001.
ANX =  anxiety; AGO = agraphobia; DEP = depression; SOM = somatization; IN = cognitive diffi 
culties; SEN = interpersonal sensitivity; HOS =  hostility; SLP =  sleep; PSN = psychoncuroticism.
T a b l e  IV. —M e a n  S I P - s c o r e s  ( s d )  o f  296 p a t i e n t s  w i t h  CFS, c o m p a r i s o n  g r o u p  1 
(450 f a m i l y  p r a c t i c e  p a t i e n t s  w i t h  p h y s i c a l  c o m p l a i n t s  o f  m i n o r  s e v e r i t y  o r  n o
PHYSICAL COMPLAINTS AT ALL) AND COMPARISON GROUP 2 (144 FAMILY PRACTICE
PATIENTS WITH MODERATE TO SEVERE PHYSICAL COMPLAINTS)
Comparison group 1 Comparison group 2 CFS
SR 2.8 (6 .2 )* 10.7 (10.7)* 16.6 (1 1.7)
HM 2.1 (8.4)* 13.4 (16.1) 15.7 (10.1)
MOB 1.2 (5.8)* 6.2 ( 10.8 )* 9.5 (9.5)
SI 2.3 (6.3)* 9.2 (11.4)* 14.9 (10.4)
A 1.4 (5.2)* 8,0 (11.5) 7.8 (8,1)
AB 2.5 (9.0)* 11.1 (18.2)* 30.7 (20.6)
W 4.5 (15.0)* 16.1 (28.4)* 25.2 (16.9)
RP 4.3 (10.3)* 18.0 (18.5) 20.0 ( 10.1)
^Significantly different from CFS: p < 0.001.
SR = sleep and rest; HM =  activities at home; MOB = mobility; SI = social interaction: 
A = ambulation; AB = alertness behaviour; W = \vork: RP =  recreation and pastimes.
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two items, 26% scored on three items, and 43% scored on four items. Overall analyses 
of variance revealed group differences on CIS-Activity (p < 0.001). Age and sex were 
entered as covariates in the analyses. Sec Table II for mean scores, standard 
deviations, and group differences.
Cognitions. Eighty-six per cent of patients reported a physical explanation for their 
complaints (predominantly viral infection), whereas only 7% reported a psychologi­
cal explanation. Thirty-nine per cent of the patients believed that they could influence 
their complaints (positive self-efficacy), 27% did not know, and 35% believed that this 
would not be possible (negative self-efficacy). Compared to FBD-patients, CFS- 
patients showed less internal attributions regarding health in general (MHLC-I; 
p < 0.001) and had less confidence in powerful others (MHLC-P: p < 0.001). There 
was no significant difference between these two groups with respect to external 
attributions (MHLC-E).
Social interactions. Twenty-seven per cent of patients reported difficulties in social 
relations and 29% reported not being satisfied with social interactions. On the SIP- 
social functioning (SIP-SI) subscale, CFS-patients showed more problems in social 
interactions than patients with moderate to severe physical complaints (see Table IV).
Sleep disturbances. Although 43% of patients reported to have sleep disturbances 
spontaneously (see Table I), 61% of patients reported sleep disturbances when 
specifically asked (of those patients, 56% had problems falling alseep, 67% had 
restless sleep, and 27% woke up early in the morning). Average duration of sleep at 
night was 8 h (range 3-14) and during the day 2 h (range 1-11). For SCL-SLP results, 
see Table III.
Neuropsychological complaints. A total of 59% reported memory and/or concen­
tration problems (see also Table I). Neuropsychological problems are also expressed 
in high scores on CIS-Concentration (Table II) and SIP-alertness behaviour (SIP-AB: 
Table IV). Overall analyses of variance revealed group differences in CIS-Concentra­
tion (/; < 0.001) and SIP-AB [p < 0.001). For significant differences between groups 
for CIS-concentration see Table II and for SIP-AB see Table IV.
Dimensions
Principal components analysis yielded a 9-factor solution (see Table V). The first 
eight factors were easily interpreted and were named: psychological well-being, 
functional impairment in daily life, sleep disturbances, avoidance behaviour, concen­
tration problems, causal attributions related to the complaints, social functioning, 
and self-efficacy expectations. The ninth factor was somewhat more difficult to 
interpret. It contains variables that would have been expected to be included in other 
dimensions. The general question 'problems in housekeeping/work’, for example, 
would have been expected to be included in the dimension functional impairment. 
What the variables in this factor have in common, in contrast with variables that are 
included in the other eight dimensions, is that they represent highly subjective general 
interpretations of the personal situation. On the SIP, for example, respondents mark 
a list of specific situations as either present or absent. Hence, less subjective 
interpretation is required than is the case in evaluating the extent to which complaints 
interfere with daily functioning in general. The variables in this dimension tap 
another mode of responding. This dimension could be named ‘subjective experience'.
Reliability analyses resulted in Cronbach's alphas varying from 0.62 to 0.91 (see
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T a v l e  V. D i m e n s i o n s  o f  CFS, c o m p o s i n g  v a r i a b l e s ,  a n d  C r o n b a c h  a l p h a  r e l i a b i l i t y  c o e f f i c i e n t s
OF THE DIMENSIONS
Dimension Variables
Cronbach's
alpha
Psychological well-being SCL-ANX; SCL-AGO; SCL-DEP; 
SCL-SEN; SCL-IN; SCL-SOM; BDI
0.91
Functional impairment SIP-HH; SIP-A; SIP-MOB 0.80
Sleep disturbances Sleep disturbances; SCL-SLP 0.78
Avoidance physical activity Avoidance of physical activity items 0.63
Neuropsychological functioning SIP-AB; CIS-concentration 0.84
Social functioning Problems relations; 
Satisfaction social life; 
SIP-SI
0.62
Causal attributions Physical attributions; 
Non-physical attributions
0.71
Self-efficacy expectations Self-efficacy expectations; 
MHLC-internal
0.77
Subjective experience Problems in housekeeping/work; 
CIS-activity;
Satisfaction in daily life; 
CIS-subjective fatigue
0.75
Tabic V for detailed information on variables finally included in each dimension and 
dimension reliability coefficients. Variables are ordered according to the magnitude of 
their primary factor loading).
Stepwise multiple regression analyses were performed to evaluate the interrelations 
between dimensions. Each of the nine dimensions served as the dependent variable 
consecutively with the remaining dimensions as the independent variables. As the 
subjective experience dimension represents another mode of responding, this dimen­
sion was excluded as an independent variable from all regression analyses. In these 
analyses the number of excluded cases exceeded 5%. Therefore, for all regression 
analyses missing values were replaced using the linear trend at point method. Results 
are displayed in Table VI (variables are ordered according to the step number they 
were entered into the model). The analyses show that, although the dimensions are 
interrelated, the combined effect of related dimensions can explain only a minor to 
moderate part of the variance. Also, regression analyses were performed with fatigue 
severity (CIS-subjective fatigue subscale), being the principal complaint in CFS, as 
the dependent variable. Fatigue severity was predicted by the dimensions psychologi­
cal well-being, functional impairment, and self-efficacy expectations (7?: = 0.51; 
variance explained: 27%).
DISCUSSION
In the present study a multi-dimensional approach to the assessment of CFS was 
developed. This study identified nine dimensions, measuring emotional, behavioural, 
cognitive, and social functioning. Multiple regression analyses showed that, although 
interrelations between the dimensions exist, the combined effect of related dimensions 
explained only a minor to moderate part of variance. Hence, each dimension provides 
a unique contribution to the assessment of CFS. Comprehensive assessment of CFS 
then implies measurement of different dimensions simultaneously.
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T a b l e  VI. S t e p w i s e  m u l t i p l e  r e g r e s s i o n  a n a l y s e s  w i t h  d i m e n s i o n s  a n d  f a t i g u e  s e v e r i t y
Independent Variables
Dependent variable Dimensions in model R2 (% variance
explained)
Psychological well-being Concentration 
Sleep disturbances 
Social functioning 
Causal attributions 
Functional impairment
0.69 (47%)
Functional impairment Social functioning 
Avoidance physical activity 
Psychological well-being
0.46 (22%)
Sleep disturbances Psychological well-being 0.45 (20%)
Avoidance physical activity Functional impairment 0.29 (8%)
Concentration Psychological well-being 
Social functioning 
Functional impairment 
Causal attributions
0.61 (38%)
Social functioning Concentration 
Psychological well-being
0.57 (33%)
Functional impairment •
Self-efficacy Psychological well-being 0.13 (2%)
Causal attributions Psychological well-being 
Concentration
0.19 (3%)
Subjective experience Functional impairment 
Concentration 
Self-efficacy 
Social functioning 
Psychological well-being
0.62 (39%)
Fatigue severity (CIS subscale subjective Psychological well-being 0.53 (28%)
fatigue) Functional impairment 
Self-efficacy
A recently developed multi-dimensional questionnaire is the Profile of Fatigue- 
Related Symptoms (PFRS) [24, 25], which has four subscales: emotional distress, 
cognitive difficulty, fatigue and somatic symptoms. The PFRS was developed to 
provide a measure of severity and pattern of illness. The PFRS resembles the CIS 
used in this study, although the former only gives information on symptoms whereas 
the CIS also provides data on behaviour. The PFRS may be a suitable instrument for 
the assessment of symptoms, but comprehensive assessment of CFS goes further than 
just symptoms.
Eifert and Wilson [26] cautioned for methodological piftalls in multi-dimensional 
assessment. Studies on the relationships between different dimensions can be con­
founded by the use of different methods of assessment across the dimensions. The 
surfacing of a set of variables that requires a higher degree of subjective interpretation 
as a separate dimension (subjective experience), in contrast to the standardized 
psychological instruments measuring the same concept, supports this notion. Since 
different modes of assessment may yield different results, it is appropriate to measure 
every dimension by different methods. We are currently carrying out studies in which, 
apart from self-report, other modes of assessment are also being used. These include 
standardized neuropsychological laboratory tests, the actometer (an apparatus to
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measure the level of physical activity), and self-monitoring. The use of multiple 
measures increases the complexity of the method, and results in rather a vast package 
of instruments. This is clearly a disadvantage in clinical practice. In research settings, 
however, multi-dimensional assessment in CFS has many advantages. This method 
provides a comprehensive assessment of patients with CFS. Clinical status, disability, 
and other relevant processes are measured. Multi-dimensional assessment may fill the 
void that exists in methods to identify homogeneous (sub)groups in patients with 
unexplained chronic fatigue. Studies that evaluate the effects of therapeutic interven­
tions should concentrate not only on a possible reduction in fatigue severity or other 
symptoms, but also on the effects of treatment on other aspects of the patients' 
functioning. Also, a multi-dimensional assessment might be useful in tailoring 
therapy to the individual patient.
Some critical remarks with respect to the present study have to be made. The 
sample was self-referred. Generalizing results to other cohorts of patients with CFS 
might then be difficult. To test generalizability, the present study sample was 
compared with a recently tested group of 68 patients with unexplained fatigue who 
were referred to the General Internal Medicine out-patient clinic of our hospital by 
their family doctor or a specialist. There were no differences between groups with 
respect to socio-demographic data or any other measure we used, except that self­
referred patients reported more complaints and had a longer duration of complaints.
Information on physical abnormalities and treatment relied on self-report. This 
made the exclusion of patients with a medical condition known to produce fatigue 
difficult. To overcome this problem as far as possible, complaints had to have been 
present for more than 1 year. This minimalized the risk of including patients with 
delayed convalescence of a viral infection. Moreover, we excluded all patients who 
had not been investigated by at least one specialist.
The dimensions we have found should not be considered as exhaustive in 
measuring all relevant aspects of CFS, nor is it said that the identified dimensions 
should be measured by the instruments used in the present study. But the main theme 
here is that, to get a comprehensive picture of CFS, a multi-dimensional approach 
should be applied.
R EFER EN C ES
1. H o l m e s  GP. K a p l a n  JE, G a n t z  NM, et al. Chronic fatigue syndrome: a working case definition. Ann 
Intern Med  1988; 108: 387-389.
2. L l o y d  AR. W a k e f i e l d  A, B o u g h t o n  CR, D n v y e r  J. What is myalgic encephalomyelitis? Lancet 1988; 
ii: 100- 101.
3. S c h l u e d e r b e r g  A, S t r a u s s  S E ,  P e t e r s o n  P .  B l u m e n t h a l  S,  K o m a r o f f  AL, S p r i n g  SB, L a n d a y  A, 
B u c h w a l d  D. N1H conference. Chronic fatigue syndrome research. Definition and medical outcome 
assessment. Ann Intern Med  1992; 117: 325-331.
4. S h a r p e  MC, A r c h a r d  LC, B a n a t v a l a  JE, B o r y s i e w i c z  LK, C l a r e  AW. D a v i d  A .  et al. A  report 
chronic fatigue syndrome: guidelines for research. J R Soc Med  1991; 84: 118-121.
5. C h e n  MK. The epidemiology o f  self-perceived fatigue among adults. Prev Med  1986; 15: 74 81.
6 . K r o e n k e  K ,  W o o d  DR, M a n g e l s d o r f f  AD, M e i e r  NJ, P o w e l l  JB. Chronic fatigue in primary care. 
Prevalence, patient characteristics, and outcome. JAMA  1988; 260: 929-934.
7. D a v i d  A, P e l o s i  A, M c D o n a l d  E, S t e p h e n s  D ,  L e d g e r  D ,  R a t h b o n e  R ,  M a n n  A. Tired, weak, or in 
need of rest: fatigue among general practice attenders. Br Med J 1990; 301: 1199-1202.
8. K e n n e d y  HG. Fatigue and fatiguability. Br J Psychiatry 1988 ;  153: 1 - 5 .
9. B a r o f s k y  I, W e s t  L e g r o  M. Definition and measurement of fatigue. Rev Infect Dis 1991; 13(Suppl 1): 
s94—97.
392 J. H. M. M. Vercoulen e t  a l
10. W e s s e l y  S, P o w e l l  R .  Fatigue syndromes: a comparison of chronic “ postviral” fatigue with 
neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry 1989: 52: 940-948.
11. B l a k e l y  AA, H o w a r d  RC, S o s i c h  RM, C a m p b e l l  M u r d o c h  J. M e n k e s  DB, S p e a r s  G F S .  
Psychiatric symptoms, personality and ways o f  coping in chronic fatigue syndrome. Psychol M ed  1991: 
21: 347-362.
12. B u c h w a l d  D, K o m a r o f f  AL. Review of laboratory findings for patients with chronic fatigue 
syndrome. Rev Infect Dis 1991; 13(Suppl 1): s73—83.
13. L a n e  TJ. M a t t h e w s  DA. M a n u  P. The low yield o f  physical examinations and laboratory 
investigations of  patients with chronic fatigue syndrome. Am J Med Sci 1990; 299: 313-318.
14. V a l d i n i  A ,  S t e i n h a r d t  S,  F e l d m a n  E.  Usefulness of  a standard battery o f  laboratory tests in 
investigating chronic fatigue syndrome. Fam Pract 1989; 6 : 286-291.
15. S w a n i n k  C M A ,  V e r c o u l e n  JH M M , B l e i j e n b e r g  G ,  F e n n i s  JFM . G a l a m a  JM D, v a n  d e r  M e e r  
JWM. The chronic fatigue syndrome: a multidisciplinary approach. (Submitted).
16. B e c k  AT, W a r d  CH, M e n d e l s o n  M ,  M o c k  J E ,  E r b a u g h  J K .  An inventory for measuring 
depression. Arch Gen Psychiatry 1961; 4: 561-571.
17. A r r i n d e l l  WA, E t t e m a  JHM . SCL-90: handleiding hij ecu multi-dimensionele psychopathologie- 
indicator. Lisse: Swets & Zeitlinger, 1986.
18. B e r g n e r  M. B o b b i t  RA, C a r t e r  W B ,  G i l s o n  BS. The Sickness Impact Profile: development and final 
revision of a health status measure. Med Care 1981; 19: 787-805.
19. J a c o b s  HM, L u t t i k  A. T o u w - O t t e n  FW M M , M e l k e r  RA. Do ‘sickness impact profile’; resultaten 
van cen valideringsonderzoek van de Nederlandse vcrsie. Ned Tijdschr Geneesk 1990; 134: 1950-1954.
20. B u t l e r  S, C h a l d e r  T, R o n  M, W e s s e l y  S. Cognitive behaviour therapy in chronic fatigue syndrome. 
J Neurol Neurosurg Psychiatry 1991; 54: 153-158.
21. W e s s e l y  S. B u t l e r  S. C h a l d e r  T, D a v i d  A. The cognitive behavioral management of  the post-viral 
fatigue syndrome. In Post-viral Fatigue Syndrome (Edited by R J e n k i n s  and J M o w b r a y ) ,  pp. 305- 
334. Chichester: Wiley, 1991.
22. W a l l s t o n  KA, W a l l s t o n  BS. D e V e l l i s  R .  Development of  the Multidimensional Health Locus of 
Control (M H LC) Scales. Health Education Monographs 1978; 6 : 160-170.
23. H a l f e n s  R, P h i l i p s e n  H .  Een gezondheidsspecifieke beheersingsoricntatieschaal: validiteit en 
betrouwbaarheid van de M HLC. T Soc Gezondh 1988; 66: 399-403.
24. R a y  C ,  W e i r  WRC, P h i l i p s  S,  C u l l e n  S. Development of a measure of  symptoms in chronic fatigue 
syndrome: the profile o f  fatigue-related symptoms ( P F R S \  Psychol Health 1992; 7: 27—43.
25. R a y  C ,  W e i r  WRC, C u l l e n  S, P h i l l i p s  S. Illness perception and symptom components in chronic 
fatigue syndrome. J Psychosom Res 1992; 36: 243-256.
26. E i f f e r t  GH. W i l s o n  PI I. The triple response approach to assessment: a conceptual and methodologi­
cal reappraisal. Behav Res Ther 1991; 29: 283-292.
